Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513370
Status:
COMPLETED
Last Update Posted:
2011-04-11
First Post:
2007-08-06
Brief Title:
A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
Sponsor:
Organization:
Abbott